4//SEC Filing
Gould Robert J 4
Accession 0000899243-22-024527
CIK 0001680581other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 5:00 PM ET
Size
5.4 KB
Accession
0000899243-22-024527
Insider Transaction Report
Form 4
Gould Robert J
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-27+19,000→ 19,000 totalExercise: $5.22Exp: 2032-06-26→ Common Stock (19,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 27, 2022 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001577034
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 5:00 PM ET
- Size
- 5.4 KB